Adam Steensberg
executiveMale0.0Global Dominance: 0.00%
Adam Steensberg is the CEO of Zealand Pharma, a Danish biopharmaceutical company focused on developing innovative therapies for obesity. He has emphasized the importance of not only achieving weight loss in patients but also helping them maintain that loss, addressing the challenges of traditional obesity treatments.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Adam Steensberg, the CEO of Zealand Pharma, discusses the company's plans for phase 3 studies.
Zealand Pharma får milliardunderskud efter større investeringerPolitiken·
Denmark· 2025-02-20
Denmark· 2025-02-20Adam Steensberg, CEO of Zealand Pharma, discusses the challenges of maintaining weight loss with current drugs.
¿Quién será el nuevo Ozempic? El mercado acelera la búsqueda de la siguiente revolución en la lucha contra la obesidad | Mercados FinancierosEl País·
Spain· 2025-02-10
Spain· 2025-02-10
